DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 59 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,173,471 | +8.4% | 177,137 | +5.5% | 0.00% | 0.0% |
| Q2 2023 | $2,004,941 | -10.9% | 167,918 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $2,250,639 | +522.2% | 168,335 | +901.4% | 0.00% | – |
| Q4 2022 | $361,751 | +55.9% | 16,810 | +44.9% | 0.00% | – |
| Q3 2022 | $232,000 | +17.2% | 11,598 | +5.0% | 0.00% | – |
| Q2 2022 | $198,000 | +50.0% | 11,044 | -16.7% | 0.00% | – |
| Q1 2022 | $132,000 | +16.8% | 13,263 | +97.9% | 0.00% | – |
| Q4 2021 | $113,000 | -24.7% | 6,702 | +5.7% | 0.00% | – |
| Q3 2021 | $150,000 | – | 6,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |